Hybrid Conferencee

International Conference on Treatments in Dermatology (ICOTID - 27)

30th - 31st March 2027 | Birmingham, UK
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 30–31 March 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 4 SDGs SDGs 3, 4, 9 and 10
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

30 MAR 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Innovations in Acne Treatment
    34
    Track Overview

    This track focuses on the latest advancements in acne treatment methodologies, including pharmacological and non-pharmacological approaches. Participants will explore emerging therapies and their clinical efficacy in managing acne vulgaris.

    Track 02
    Advancements in Melanoma Diagnosis
    39
    Track Overview

    This session will delve into cutting-edge techniques and technologies for the early detection and diagnosis of melanoma. Discussions will include the role of dermatoscopy, histopathology, and molecular diagnostics.

    Track 03
    Management of Blistering Disorders
    34
    Track Overview

    This track addresses the complexities involved in diagnosing and managing various blistering disorders, including pemphigus and bullous pemphigoid. Experts will share insights on treatment strategies and patient care.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Autoimmune Skin Diseases: Challenges and Solutions
    310
    Track Overview

    Focusing on autoimmune skin diseases, this session will cover the pathophysiology, clinical manifestations, and therapeutic options available. Participants will engage in discussions on personalized medicine approaches in treatment.

    Track 05
    Psoriasis: From Pathogenesis to Treatment
    34
    Track Overview

    This track will explore the underlying mechanisms of psoriasis and the latest therapeutic interventions. Emphasis will be placed on biologics, systemic therapies, and emerging treatment modalities.

    Track 06
    Skin Appendage Disorders: Diagnosis and Management
    34
    Track Overview

    This session will focus on conditions affecting skin appendages, including hair and nail disorders. Participants will discuss diagnostic techniques and management strategies for conditions such as onychomycosis and folliculitis.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

31 MAR 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Phototherapy in Dermatology: Current Practices
    34
    Track Overview

    This track will examine the role of phototherapy in treating various skin conditions, including psoriasis and eczema. Experts will discuss the mechanisms, efficacy, and safety of different phototherapeutic modalities.

    Track 08
    Patch Testing for Skin Allergies
    34
    Track Overview

    This session will cover the principles and practices of patch testing in diagnosing contact dermatitis and other skin allergies. Participants will learn about the latest allergens and testing protocols.

    Track 09
    Erysipelas and Cellulitis: Clinical Insights
    34
    Track Overview

    Focusing on erysipelas and cellulitis, this track will discuss the clinical presentation, diagnosis, and management of these common skin infections. Experts will share strategies for effective treatment and prevention.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Congenital Anomalies of the Skin: A Comprehensive Review
    34
    Track Overview

    This session will provide an overview of congenital skin anomalies, their clinical features, and management options. Participants will discuss the implications for patient care and the latest research in this area.

    Track 11
    Auto-inflammatory Syndromes in Dermatology
    34
    Track Overview

    This track will explore the role of auto-inflammatory syndromes in dermatological practice, focusing on their diagnosis and management. Participants will engage in discussions on the latest research and therapeutic advancements.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities

Be Part of ICOTID-27

Submit your research or complete your conference registration.